Effects of Routine Infant Vaccination With the 7-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization With Streptococcus pneumoniae in Children in Calgary, Canada
- 1 June 2008
- journal article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 27 (6) , 526-532
- https://doi.org/10.1097/inf.0b013e3181658c5c
Abstract
Background: All Streptococcus pneumoniae disease is preceded by nasopharyngeal (NP) colonization. We studied the impact of 7-valent pneumococcal conjugate vaccine (PCV7) on colonization in healthy children. Methods: Routine PCV7 vaccination began in Alberta in 2002. Six point prevalence surveys were conducted from 2003 to 2005, in 7 community health centers in Calgary where children had their routine vaccinations. A questionnaire was administered and a single NP swab was obtained for culture. Serotyping was performed on all S. pneumoniae isolates. Results: There were 3398 children with complete data, 1307, 1225, and 866 in 12-month, 18-month, and 4–6 year groups, respectively. None had received PCV7 in survey 1. From survey 2 onwards, 92–98% of 12-month-olds had 3 or more doses of PCV7, and from survey 3 onwards, 95–99% of 18-month-olds had 3 or more doses. By survey 6, only 4% of 4–6 year olds had 3 or more doses. The overall S. pneumoniae colonization rate was 20%. In all age groups, including unvaccinated 4–6 year olds, there were significant declines in PCV7 serotypes, and increases in non-PCV7 serotypes. The largest increases were serotypes 6A, 15C, and 11A. Multivariate analysis found that factors including age, siblings, daycare attendance, episodes of otitis media, and antibiotic use affected S. pneumoniae colonization but only PCV7 vaccination was associated with decreased PCV7 serotype colonization and increased non-PCV7 colonization. Conclusions: Routine PCV7 vaccination has led to significant changes in the predominant S. pneumoniae serotypes found in NP colonization in both vaccinated and unvaccinated children, indicating both a direct and herd effect.Keywords
This publication has 31 references indexed in Scilit:
- Immunologic Considerations for the Timing of the Booster Dose of 7-Valent Pneumococcal Conjugate Vaccine in Young ChildrenThe Pediatric Infectious Disease Journal, 2007
- Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes Among Alaska Native Children With High Levels of 7-Valent Pneumococcal Conjugate Vaccine CoverageJAMA, 2007
- Impact of Pneumococcal Conjugate Vaccine and of Reduction of Antibiotic Use on Nasopharyngeal Carriage of Nonsusceptible Pneumococci in Children With Acute Otitis MediaThe Pediatric Infectious Disease Journal, 2006
- Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control studyThe Lancet, 2006
- Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2–7 months of ageVaccine, 2006
- Progress in the prevention of pneumococcal infectionCMAJ : Canadian Medical Association Journal, 2005
- Effect of the Seven-Valent Conjugate Pneumococcal Vaccine on Carriage and Drug Resistance of Streptococcus pneumoniae in Healthy Children Attending Day-Care Centers in LisbonThe Pediatric Infectious Disease Journal, 2005
- Epidemiological differences among pneumococcal serotypesThe Lancet Infectious Diseases, 2005
- Streptococcus pneumoniae colonisation: the key to pneumococcal diseaseThe Lancet Infectious Diseases, 2004
- Pneumococcal nasopharyngeal carriage in children following heptavalent pneumococcal conjugate vaccination in infancyArchives of Disease in Childhood, 2003